23andMe (ME) - 2025 Q2 - Quarterly Results

EXHIBIT 99.1 23andMe Reports Second Quarter Fiscal Year 2025 Financial Results SUNNYVALE, Calif., November. 12, 2024 -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, reported its financial results for the second quarter of fiscal year 2025 (FY25), which ended September 30, 2024. Key Results: • Improved GAAP Net Loss by 21% and Adjusted EBITDA by 26% for the same period in the prior year (see important additional information below). • The 23andMe comprehensive Tota ...